News & Updates

Despite encouraging in vivo evidence, antiseptic mouthwashes do not substantially reduce the coronavirus disease 2019 (COVID-19) viral load in saliva, a recent study has found.

The novel oral SERD* elacestrant demonstrated potential as new treatment alternative for ER+/HER2– advanced/metastatic breast cancer (mBC) following progression on prior endocrine and CDK4/6 inhibitor therapy, according to the phase III EMERALD trial.

Though decreasing over time, early mortality remains high in patients with multiple myeloma (MM), a recent study has found. Important risk factors include older age, a more aggressive disease, and a patient’s poor physical condition.